Closed
The Marked Chart Wire · Business
Stellantis
Stellantis reported a smaller net loss and higher adjusted operating income in the third quarter, driven by revenue growth despite lower vehicle shipments. The company confirmed its full-year 2026 outlook.
Prices from Before the open · based on Tue close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
Stellantis
The European automaker disclosed a 4 billion euro cash drain during the period as it executes its ongoing turnaround strategy.
Stellantis
The automaker reaffirmed its outlook for mid-single-digit revenue growth and low-single-digit adjusted operating margins in 2026. It also expects positive industrial free cash flow in 2027.
GE HealthCare
The company reported non-GAAP earnings of $1.34 per share, exceeding expectations by $0.14. Revenue reached $5.51 billion, topping forecasts by $160 million, while management increased its annual guidance.
Meta
Meta shares dropped 11 percent last week after Q3 results showed negative free cash flow and a proposed $97 billion asset sale. Canaccord analysts maintain a positive outlook on the stock.
Biogen
Biogen revised its full-year 2026 adjusted earnings per share outlook to a range of $15.95 to $16.75, down from the previous $15.85 to $16.85. The new midpoint sits above the $12.36 analyst estimate.
UMC Earnings
The chipmaker reported third-quarter earnings per share of $0.21, below the $0.23 expected by analysts. Revenue came in at $2.32 billion, falling short of the $2.35 billion forecast.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.